DCBLD2 Gene Variations Correlate with Nasal Polyposis in Korean Asthma Patients

Department of Life Science, Sogang University, Seoul 121-742, Republic of Korea.
Beiträge zur Klinik der Tuberkulose (Impact Factor: 2.27). 01/2012; 190(2):199-207. DOI: 10.1007/s00408-011-9354-8
Source: PubMed


Nasal polyps are abnormal lesions that cause airway obstruction and can occur along with other respiratory diseases. On account of its association with aspirin exacerbated respiratory disease (AERD), the human discoidin, CUB and LCCL domain containing 2 (DCBLD2) is hypothesized to be a candidate gene for the development of nasal polyps in asthma patients.
A total of 12 single-nucleotide polymorphisms (SNPs) were genotyped in 467 Korean asthma patients who were stratified further into 108 AERD and 353 aspirin-tolerant asthma (ATA) subgroups. Five major haplotypes were inferred from pairwise comparison of the polymorphisms. The patients were matched to control for confounds, and differences in the frequency distribution of DCBLD2 SNPs and haplotypes were analyzed using logistic models via various modes of genetic inheritance.
Results reveal significant association of rs828618 and DCBLD2_ht1 with nasal polyposis in the overall asthma patients group (P = 0.006, P(corr) = 0.05). Interestingly, the strength of association were maintained in the ATA subgroup (P = 0.007, P(corr) = 0.06), and moderate correlation was detected in the AERD subgroup (P = 0.04-0.05, P(corr) > 0.05).
Although further replication and validation are needed, these findings suggest that DCBLD2 could be a potential marker and drug target for treatment of nasal polyposis in Korean asthma patients.

Download full-text


Available from: Charisse Flerida Pasaje, Nov 13, 2014
  • [Show abstract] [Hide abstract]
    ABSTRACT: The cause of chronic rhinosinusitis (CRS) remains unclear. Study of the genetic susceptibility to CRS might be a valuable strategy to understand the pathogenesis of this burdensome disorder. The purpose of this review is to critically evaluate the current literature regarding the genetics of CRS in a comprehensive fashion. The most promising findings from candidate gene studies include the cystic fibrosis transmembrane conductance regulator gene (CFTR), as well as genes involved in antigen presentation, innate and adaptive immune responses, tissue remodeling, and arachidonic acid metabolism. We also review the few hypothesis-independent genetic studies of CRS (ie, linkage analysis and pooling-based genome-wide association studies). Interpretation of the current literature is limited by challenges with study design, sparse replication, few functional correlates of associated polymorphisms, and inadequate examination of linkage disequilibrium or expression quantitative trait loci for reported associations. Given the relationship of CRS to other airway disorders with well-characterized genetic components (eg, asthma), study of the genetics of CRS deserves increased attention and investment, including the organization of large, detailed, and collaborative studies to advance knowledge of the mechanisms that underlie this disorder.
    The Journal of allergy and clinical immunology 04/2013; 131(4):977-993.e5. DOI:10.1016/j.jaci.2013.01.028 · 11.48 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Platelets and Aspirin-Induced Asthma is the first book to be published that reflects research conducted on aspirin-induced asthma pathogenesis. It is examined through positions of neuroimmunoendocrine interactions in organism. The Melatonin hormone plays a key role, being the regulator and coordinator of complicated and interrelated biological processes. This new concept of aspirin-induced asthma pathogenesis suggests new methods for treatment of this disease by means of correcting the melatonin content in the patient's organism. Investigations into the mechanisms of aspirin-induced asthma as a pathology of melatonin producing cells of platelets helps to determine high-risk groups and develop preventive measures and adequate therapy. The first book to examine the role of platelets, melatonin and diffuse neuroimmunoendocrine system in the pathogenesis of aspirin-induced asthma. Proposes a new concept of aspirin-induced asthma pathogenesis that suggests new diagnostic and treatment methods for the disease.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Aberrant activation of EGFR-Akt signaling frequently occurs in GBMs and promotes tumorigenesis, progression and invasion. Activation of the oncogenic EGFR-Akt signaling in cancers is caused by gene amplification, overexpression, or activating mutations of EGFR. In this study, we describe a novel function of Discoidin, CUC and LCCL domain containing protein 2 (DCBLD2), an orphan membrane receptor that has an unclear role in human cancers. DCBLD2 is up-regulated in glioblastomas (GBMs) and head & neck cancers (HNCs) and is required for EGFR-stimulated tumorigenesis. We show that EGFR activates tyrosine phosphorylation (p-Y) of the DCBLD2 Y750 residue, located within a newly identified binding motif for TNF receptor-associated factor 6 (TRAF6). Consequently, activation of p-DCBLD2Y750 recruits TRAF6 to DCBLD2. This association causes increased TRAF6 E3 ubiquitin ligase activity and subsequent activation of Akt, thereby enhancing EGFR-driven tumorigenesis. Our findings uncover a novel pathway by which DCBLD2 functions as a signal relay for oncogenic EGFR signaling in promoting tumorigenesis, a conclusion that is supported by the association of EGFR activation and DCBLD2 phosphorylation with poor prognoses for gliomas and HNCs. These data also nominate DCBLD2 and TRAF6 as attractive therapeutic targets for human cancers that are associated with EGFR activation.
    The Journal of clinical investigation 07/2014; DOI:10.1172/JCI73093 · 13.22 Impact Factor